Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2018 1
2019 1
2020 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Epidemiology of IgA Nephropathy: A Global Perspective.
Schena FP, Nistor I. Schena FP, et al. Semin Nephrol. 2018 Sep;38(5):435-442. doi: 10.1016/j.semnephrol.2018.05.013. Semin Nephrol. 2018. PMID: 30177015
IgA nephropathy (IgAN), or Berger's disease, is the most common primary glomerular disease worldwide, but varies largely in its geographic distribution. ...All observational studies that described the prevalence and incidence data on glomerulonephritis were c
IgA nephropathy (IgAN), or Berger's disease, is the most common primary glomerular disease worldwide, but varies largely in it
Global Incidence of IgA Nephropathy by Race and Ethnicity: A Systematic Review.
Kiryluk K, Freedberg DE, Radhakrishnan J, Segall L, Jacobson JS, Mathur M, Mohan S, Neugut AI. Kiryluk K, et al. Kidney360. 2023 Aug 1;4(8):1112-1122. doi: 10.34067/KID.0000000000000165. Epub 2023 May 25. Kidney360. 2023. PMID: 37227924 Free PMC article.
Studies were eligible for inclusion if they contained data collected from January 1, 1974, to December 31, 2021, and reported IgA nephropathy incidence at a population level (i.e., cases of IgA nephropathy per 100,000 population). ...CONCLUSIONS: Repor …
Studies were eligible for inclusion if they contained data collected from January 1, 1974, to December 31, 2021, and reported IgA
The incidence of primary glomerulonephritis worldwide: a systematic review of the literature.
McGrogan A, Franssen CF, de Vries CS. McGrogan A, et al. Nephrol Dial Transplant. 2011 Feb;26(2):414-30. doi: 10.1093/ndt/gfq665. Epub 2010 Nov 10. Nephrol Dial Transplant. 2011. PMID: 21068142 Review.
Rates for the individual types of disease were found to be in adults, 0.2/100,000/year for membrano-proliferative GN, 0.2/100,000/year for mesangio-proliferative GN, 0.6/100,000/year for minimal change disease, 0.8/100,000/year for focal segmental glomerulosclerosis, 1.2/100,000/ …
Rates for the individual types of disease were found to be in adults, 0.2/100,000/year for membrano-proliferative GN, 0.2/100,000/year for m …
Prevalence and distribution of primary glomerular diseases in Africa: a systematic review and meta-analysis of observational studies.
Ekrikpo UE, Obiagwu PN, Udo AI, Chukwuonye II, Noubiap JJ, Okpechi-Samuel US, Udoudo UN, Tannor EK, Ngoka SC, Mbah IO, Bello AK, Okpechi IG. Ekrikpo UE, et al. Pan Afr Med J. 2023 Aug 9;45:153. doi: 10.11604/pamj.2023.45.153.40741. eCollection 2023. Pan Afr Med J. 2023. PMID: 37869232 Free PMC article. Review.
Glomerulonephritis (GN) is a predominant cause of kidney failure in Africa. ...Data for primary GNs [minimal change disease (MCD), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN), mesangioproliferative GN (MesPGN), membranoproliferative GN (MP
Glomerulonephritis (GN) is a predominant cause of kidney failure in Africa. ...Data for primary GNs [minimal change disease (MCD), fo
Immunosuppressive agents for treating IgA nephropathy.
Natale P, Palmer SC, Ruospo M, Saglimbene VM, Craig JC, Vecchio M, Samuels JA, Molony DA, Schena FP, Strippoli GF. Natale P, et al. Cochrane Database Syst Rev. 2020 Mar 12;3(3):CD003965. doi: 10.1002/14651858.CD003965.pub3. Cochrane Database Syst Rev. 2020. PMID: 32162319 Free PMC article.
BACKGROUND: IgA nephropathy is the most common glomerulonephritis world-wide. ...There is no evidence that other immunosuppressive agents including CPA, AZA, or MMF improve clinical outcomes in IgA nephropathy....
BACKGROUND: IgA nephropathy is the most common glomerulonephritis world-wide. ...There is no evidence that other immuno …
Incidence of pediatric glomerular diseases in Arab world: A systematic review.
Alwahaibi NY, Al Issaei HK, Al Dhahli BS. Alwahaibi NY, et al. Saudi J Kidney Dis Transpl. 2019 Jan-Feb;30(1):15-23. Saudi J Kidney Dis Transpl. 2019. PMID: 30804262
Minimal change disease (MCD) (29.25%), focal and segmental glomerulosclerosis (FSGS) (22.34%), mesangioproliferative glomerulonephritis (14.78%), membranoproliferative glomerulonephritis (6.9%), IgA nephropathy (3.98%), and membranous glomerulopathy (2 …
Minimal change disease (MCD) (29.25%), focal and segmental glomerulosclerosis (FSGS) (22.34%), mesangioproliferative glomerulonephritis